ACEL - Tamir Biotechnology, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
10/22/07 10:47	10/19/07	ACEL	Health	BioPrd	Biological Products, (No Diag	Brancaccio John P	NJ	D		P	4	1.94	2	58	6	D
10/19/07 15:47	10/19/07	ACEL	Health	BioPrd	Biological Products, (No Diag	Weiss Paul M	NJ	D		P	25	1.99	13	61	34	D
4/12/07 17:07	4/11/07	ACEL	Health	BioPrd	Biological Products, (No Diag	Kenyon Lawrence A	NJ	O	EVP,CFO,	P	53	2.14	25	New	25	D
7/26/06 10:38	7/25/06	ACEL	Health	BioPrd	Biological Products, (No Diag	Loughlin James J	NJ	D		P	15	2.04	8	300	10	D
7/25/06 14:29	7/25/06	ACEL	Health	BioPrd	Biological Products, (No Diag	Love Robert Dennis	NJ	O	CFO	P	21	2.09	10	46	32	D
7/24/06 13:43	7/24/06	ACEL	Health	BioPrd	Biological Products, (No Diag	Brancaccio John P	NJ	D		P	8	2.05	4	New	4	D
12/27/05 13:01	12/23/05	ACEL	Health	BioPrd	Biological Products, (No Diag	Weiss Paul M	NJ	D		P	5	1.59	3	18	21	D
12/23/05 12:44	12/22/05	ACEL	Health	BioPrd	Biological Products, (No Diag	Love Robert Dennis	NJ	O	CFO	P	9	1.83	5	100	10	D
12/21/05 19:22	12/21/05	ACEL	Health	BioPrd	Biological Products, (No Diag	Love Robert Dennis	NJ	O	CFO	P	10	2.00	5	New	5	D
12/19/05 14:08	12/16/05	ACEL	Health	BioPrd	Biological Products, (No Diag	Weiss Paul M	NJ	D		P	5	1.95	3	17	18	D
3/16/05 15:57	3/16/05	ACEL	Health	BioPrd	Biological Products, (No Diag	Weiss Paul M	NJ	D		P	5	1.91	3	21	15	D
10/27/04 12:11	10/25/04	ACEL	Health	BioPrd	Biological Products, (No Diag	Shogen Kuslima	NJ	DO	CEO	P.m	9	3.54	3	0	1,326	D
9/22/04 16:05	9/21/04	ACEL	Health	BioPrd	Biological Products, (No Diag	Loughlin James J	NJ	D		P.m	11	4.54	3	New	3	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person